[Deposition of aerosols into the airways (author's transl)]. 1978

B Gottschalk, and W Leupold, and P Woller

The rate of powder absorbed in the lung greatly depends on the particle diameter, and amounts to 40--50% for 1 micrometer particles and 15--20% for 5 micrometer particles. Of importance for therapy was the information that single breath will deposit in the lung 15% of a powder aerosol of 2 micrometer diameter. The liquid aerosols as prevalently used in the therapy, were retained in the lung at a rate of 15% of the original amount when using ultrasonic apparatus. If calculated per minute of inhalation time, the amount absorbed by the lung amounted to 0.2 ml and that by the upper respiratory tract to 0.06 ml. Best deposition in the lung was obtained when inhaling in a closed system with valve-controlled aerosol stream, when using a mouthpiece, and when the test person inhaled with low respiratory rate, deep inspirations, short respiratory pause and complete exspiration. Mark inhalation with closed mouth gave only one tenth of the lung deposition reached with the breathing method described. The use of a mask showed good results, however, when the test person was breathing with open mouth. Only 0.07 ml/min were retained with jet nebulizer and mouth respiration. Combination with intermittent pressure respiration showed no convincing results.

UI MeSH Term Description Entries
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D012138 Respiratory Therapy Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways. Inhalation Therapy,Therapy, Inhalation,Therapy, Respiratory,Inhalation Therapies,Respiratory Therapies,Therapies, Inhalation,Therapies, Respiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol

Related Publications

B Gottschalk, and W Leupold, and P Woller
January 1979, Le Poumon et le coeur,
B Gottschalk, and W Leupold, and P Woller
October 1976, Medizinische Klinik,
B Gottschalk, and W Leupold, and P Woller
January 2016, Journal of occupational and environmental hygiene,
B Gottschalk, and W Leupold, and P Woller
January 1983, Fundamental and applied toxicology : official journal of the Society of Toxicology,
B Gottschalk, and W Leupold, and P Woller
January 1979, Le Poumon et le coeur,
B Gottschalk, and W Leupold, and P Woller
January 1979, Le Poumon et le coeur,
B Gottschalk, and W Leupold, and P Woller
March 1977, Therapeutische Umschau. Revue therapeutique,
B Gottschalk, and W Leupold, and P Woller
January 1981, Revue francaise des maladies respiratoires,
B Gottschalk, and W Leupold, and P Woller
February 2021, Journal of aerosol science,
B Gottschalk, and W Leupold, and P Woller
January 2015, Journal of aerosol science,
Copied contents to your clipboard!